UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ureterovesical anastomotic techniques for kidney transplantation: a systematic review and meta‐analysis

Transplant international, 2014-06, Vol.27 (6), p.593-605

2014

Volltextzugriff (PDF)

Is the use of parasympathomimetics for treating an underactive urinary bladder evidence‐based?

BJU international, 2007-04, Vol.99 (4), p.749-752

2007

Volltextzugriff (PDF)

Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.698-705

2013

Volltextzugriff (PDF)

Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate®: Final report from a prospective study

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (2), p.221-228

2018

Volltextzugriff (PDF)

A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-07, Vol.17 (4), p.590-596

2011

Volltextzugriff (PDF)

Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.399-406

2011

Volltextzugriff (PDF)

Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.674-678

2013

Volltextzugriff (PDF)

Response to the Letter to the Editor by Ewenstein BM and Reininger AJ

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-07, Vol.19 (4), p.e257-e258

2013

Volltextzugriff (PDF)

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-03, Vol.18 (2), p.175-181

2012

Volltextzugriff (PDF)

Successful immune tolerance induction in two boys with haemophilia B and inhibitory antibodies

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.e67-e69

2012

Volltextzugriff (PDF)

Prophylaxis in children with haemophilia - the Polish experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-01, Vol.20 (1), p.e108-e110

2014

Volltextzugriff (PDF)

Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor

Haemophilia : the official journal of the World Federation of Hemophilia, 2005-01, Vol.11 (1), p.2-4

2005

Volltextzugriff (PDF)

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.760-765

2009

Volltextzugriff (PDF)

Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report

Haemophilia, 2008-07, Vol.14 (4), p.873-875

2008

Volltextzugriff (PDF)

Training of European urology residents in laparoscopy: results of a pan‐European survey

BJU international, 2013-12, Vol.112 (8), p.1223-1228

2013

Volltextzugriff (PDF)

Radiological features characterising indeterminate testes masses: a systematic review and meta‐analysis

BJU international, 2023-03, Vol.131 (3), p.288-300

2023

Volltextzugriff (PDF)

A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B: PHARMACOKINETICS, EFFICACY AND SAFETY OF ALPHANINE

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-07, Vol.17 (4), p.590-596

2011

Volltextzugriff (PDF)

Haemothorax in children with congenital coagulopathy

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (4), p.688-691

2010

Volltextzugriff (PDF)

Efficacy and safety of OCTANINE F in children with haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-05, Vol.14 (3), p.531-538

2008

Volltextzugriff (PDF)

Acquired factor VIII inhibitor in a non‐haemophilic boy

Haemophilia : the official journal of the World Federation of Hemophilia, 2003-09, Vol.9 (5), p.642-645

2003

Volltextzugriff (PDF)

Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2001-05, Vol.7 (3), p.286-292

2001

Volltextzugriff (PDF)

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-09, Vol.10 (5), p.438-448

2004

Volltextzugriff (PDF)

Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study: INCIDENCE OF FVIII INHIBITORS FOLLOWING OCTANATE® THERAPY

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.399-406

2011

Volltextzugriff (PDF)

Individual Patterns of Dynamic QT/RR Relationship in Survivors of Acute Myocardial Infarction and Their Relationship to Antiarrhythmic Efficacy of Amiodarone

Journal of cardiovascular electrophysiology, 2004-10, Vol.15 (10), p.1147-1154

2004

Volltextzugriff (PDF)

HAEMOTHORAX IN A BOY WITH SEVERE HAEMOPHILIA AND FACTOR VIII INHIBITOR

Journal of thrombosis and haemostasis, 2007-07, Vol.5, p.P-M-155-P-M-155

2007

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(156)

Publikationsform

Artikel
(153)
Berichte
(6)

Sprache

Englisch
(158)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ureterovesical anastomotic techniques for kidney transplantation: a systematic review and meta‐analysis

Is the use of parasympathomimetics for treating an underactive urinary bladder evidence‐based?

Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics

Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate®: Final report from a prospective study

A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B

Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study

Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B

Response to the Letter to the Editor by Ewenstein BM and Reininger AJ

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B

Successful immune tolerance induction in two boys with haemophilia B and inhibitory antibodies

Prophylaxis in children with haemophilia - the Polish experience

Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres

Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report

Training of European urology residents in laparoscopy: results of a pan‐European survey

Radiological features characterising indeterminate testes masses: a systematic review and meta‐analysis

A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B: PHARMACOKINETICS, EFFICACY AND SAFETY OF ALPHANINE

Haemothorax in children with congenital coagulopathy

Efficacy and safety of OCTANINE F in children with haemophilia B

Acquired factor VIII inhibitor in a non‐haemophilic boy

Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A

Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study: INCIDENCE OF FVIII INHIBITORS FOLLOWING OCTANATE® THERAPY

Individual Patterns of Dynamic QT/RR Relationship in Survivors of Acute Myocardial Infarction and Their Relationship to Antiarrhythmic Efficacy of Amiodarone

HAEMOTHORAX IN A BOY WITH SEVERE HAEMOPHILIA AND FACTOR VIII INHIBITOR

Aktive Filter

Suchergebnisse filtern